Having been over three Years on AS, I find it a little confusing that the NICE Guidelines actually reduce the level of monitoring as time goes on for patients like myself with an initial 3x3 Diagnosis.
I have only ever had one MRI in February 2017, and after my next checkup in June, I have been told they will then go to every six months Checkups at which I usually have a DRE as well, I have been told that I will not be offered another MRI or Biopsy unless my PSA or any other symptoms raise a red flag.
This is a concern to me, as I feel like I’m a little bit in limbo waiting for something to rear it’s ugly head before they will then investigate, when it could already not still be a localised cancer.
I have also only been examined by a specialist nurse for the last two years with the only question at every checkup of “is everything okay”, well I don’t know if everything is okay, what are people on AS with no clinical knowledge of Prostate Cancer supposed to look for??
NICE Guidelines: Year 2 and every year thereafter until active surveillance ends.
Every 6 months: measure PSAb
Throughout active surveillance: monitor PSA kineticsc
Every 12 months: DREd
a If there is concern about clinical or PSA changes at any time during active surveillance, reassess with multiparametric MRI and/or re‑biopsy.
b Could be carried out in primary care if there are agreed shared-care protocols and recall systems.
c Could include PSA density and velocity.
d Should be performed by a healthcare professional with expertise and confidence in performing DRE. In a large UK trial that informed this protocol, DREs were carried out by a urologist or a nurse specialist.